IHC analysis further confirmed the circFNDC3B- or RNF41-mediated downregulation of ASB6 in tumor tissues, and the proliferation marker Ki-67 and stemness marker CD133 were also reduced by circFNDC3B or RNF41 overexpression in vivo (Fig. 9J). Here, ASB6 is linked to neoplasm.